News & Analysis on Clinical Trial Services & Contract Research And Development
Tepnel announced it had completed the acquistion of Diaclone Research adding customisable monoclonal antibodies (mABs), complimentary reagents and ELISA test kits to its range of life sciences instrumentation and services.
Arena Pharmaceuticals has entered into collaboration with Ortho-McNeil Pharmaceutical to develop a new class of oral drugs for the treatment of type 2 diabetes. Arena can expect to net $300 million (€224 million) excluding milestone and royalty payments.
In-PharmaTechnologist.com's periodic round-up of developments in the pharmaceutical manufacturing sector sees Schering-Plough expanding in Japan and plant news from Germany, Mexico and Vietnam.
The ongoing controversy concerning certain drugs and a link to heart trouble gained further momentum after the Food and Drug Administration (FDA) issued a warning for the pain reliever naproxen after researchers found an increased number of heart...
At the CPhI meeting this year, many contract manufacturing organisations (CMOs) trumpeted their new investments in capacity, despite the prevailing wisdom that the pharmaceutical sector is over-served at present.
Cell culture equipment company Integra Biosciences has launched a new roller system designed to improve the cultivation of adherent and suspension cells.
UK-based Microplate manufacturers Porvair Sciences, adds to its range of microporous products that are suitable for a range of industrial and domestic applications including drug discovery, protein purification and high throughput screening.
The first study to confirm the potential of a new class of drug for neurodegenerative disorders such as Alzheimer's could herald a breakthrough in drug treatment for a disease that affects up to 4 million adults in the United States, and 10 million...